EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSNBRG00000009022
Gene Symbol: GRM4
3 Cross references
207 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSNBRG00000018592
Gene Symbol: LOC102787600
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSNBRG00000013291
Gene Symbol: LOC102783041
4 Cross references
202 Possible Orthologues:

Glutamate Receptor 3-Like

Ensembl ID : ENSNBRG00000018156
Gene Symbol: LOC102795589
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 4-Like

Ensembl ID : ENSNBRG00000013070
Gene Symbol: LOC102791202
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSNBRG00000000539
Gene Symbol: LOC102777117
3 Cross references
205 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2a-Like

Ensembl ID : ENSNBRG00000009863
Gene Symbol: LOC102797072
2 Cross references
98 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSNBRG00000002823
Gene Symbol: LOC102782376
2 Cross references
212 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 3b-Like

Ensembl ID : ENSNBRG00000009939
Gene Symbol: LOC102780046
2 Cross references
225 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSNBRG00000015505
Gene Symbol: LOC102789803
3 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase-3 Alpha-Like

Ensembl ID : ENSNBRG00000020141
Gene Symbol: LOC102792707
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase-3 Alpha-Like

Ensembl ID : ENSNBRG00000018311
Gene Symbol: LOC102777183
3 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).